Postępowanie w subklinicznej niedoczynności tarczycy u kobiet ciężarnych i dzieci

• Authors: Zdrojowy-Wełna Aleksandra , Rogala Natalia , Zatońska Katarzyna , Bednarek-Tupikowska Grażyna
• Languages of publication: PL

Keywords

PL

subkliniczna hipotyreoza; ciąża; dzieci; leczenie subklinicznej niedoczynności tarczycy

• Publisher: Stowarzyszenie Przyjaciół Medycyny Rodzinnej i Lekarzy Rodzinnych
• Journal: Family Medicine & Primary Care Review
• Year: 2015
• Issue: 1
• Pages: 60-65

Contributors

author

Zdrojowy-Wełna Aleksandra

author

Rogala Natalia

author

Zatońska Katarzyna

author

Bednarek-Tupikowska Grażyna

References

• Lazarus J, Brown RS , Daumerie C, et al. 2014 European Thyroid Association Guidelines for the management of subclinical hypothyroidism in pregnancy and in children. Eur Thyroid J 2014; 3: 76–94.
• Hubalewska-Dydejczyk A, Lewiński A, Milewicz A, i wsp. Postępowanie w chorobach tarczycy u kobiet w ciąży. Endokrynol Pol 2011; 62: 362–381.
• Li C, Shan Z, Mao J, et al. Assessment of thyroid function during first-trimester pregnancy: what is the rational upper limit of serum TS H during the first trimester in Chinese pregnant women? J Clin Endocrionol Metab 2014; 99: 73–79
• Bliddal S, Feldt-Rasmussen U, Boas M, et al. Gestational age-specific reference ranges from different laboratories misclassify pregnant women’s thyroidstatus: comparison of two longitudinal prospective cohort studies. Eur J Endocrinol 2013; 170:329–339.
• Stagnaro-Green A, Abalovich M, Alexander E, et al. Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and Postpartum. Thyroid 2011; 21: 1081–1125.
• Allan WC, Haddow JE , Palomaki GE, et al. Maternal thyroid deficiency and pregnancy complications: implications for population screening. J Med Screen 2000; 7: 127–130.
• Karakosta P, Alegakis D, Georgiou V, et al. Thyroid dysfunction and autoantibodies in early pregnancy are associated with increased risk of gestational diabetes and adverse birth outcomes. J Clin Endocrinol Metab 2012; 97: 4464–4472.
• Tudela CM, Casey BM, McIntire DD . Relationship of subclinical thyroid disease to the incidence of gestational diabetes mellitus.Obstet Gynecol 2012; 119: 983–988.
• Männistö T, Vääräsmäki M, Pouta A, et al. Perinatal outcome of children born to mothers with thyroid dysfunction or antibodies:a prospective population-based cohort study. J Clin Endocrinol Metab 2009; 94: 772–779.
• Cleary-Goldman J, Malone FD, Lambert-Messerlian G, et al. Maternal thyroid hypofunction and pregnancy outcome. Obstet Gynecol 2008; 112: 85–92.
• Negro R, Schwartz A, Gismondi R, et al. Increased pregnancy loss rate in thyroid antibody negative women with TS H levels between 2.5 and 5.0 in the first trimester of pregnancy. J Clin Endocrinol Metab 2010; 95: 44–48.
• Benhadi N, Wiersinga WM, Reitsma JB, et al. Higher maternal TS H levels in pregnancy are associated with increased risk for miscarriage, fetal or neonatal death. Eur J Endocrinol 2009; 160: 985–991.
• Wilson KL , Casey BM, McIntire DD , et al. Subclinical thyroid disease and the incidence of hypertension in pregnancy. Obstet Gynecol 2012; 119: 315–320.
• Casey BM, Dashe JS , Wells CE, et al. Subclinical hypothyroidism and pregnancy outcomes. Obstet Gynecol 2005; 105:239–245.
• Su PY , Huang K, Hao JH, et al. Maternal thyroid function in the first twenty weeks of pregnancy and subsequent fetal and infant development: a prospective population-based cohort study in China. J Clin Endocrinol Metab 2011; 96: 3234–3241.
• Korevaar TI , Schalekamp-Timmermans S, de Rijke YB, et al. Hypothyroxinemia and TPO -antibody positivity are risk factors for premature delivery: the generation R study. J Clin Endocrinol Metab 2013; 98: 4382–4390.
• Ghassabian A, Bongers-Schokking JJ , Henrichs J, et al. Maternal thyroid function during pregnancy and behavioral problems in the offspring: the generation R study. Pediatr Res 2011; 69: 454–459.
• Lazarus JH, Bestwick JP , Channon S, et al. Antenatal thyroid screening and childhood cognitive function. N Engl J Med 2012;366: 493–501.
• Julvez J, Alvarez-Pedrerol M, Rebagliato M, et al. Thyroxine levels during pregnancy in healthy women and early child neurodevelopment.Epidemiology 2013; 24: 150–157
• Pawłowicz R, Iwańczak B. Subkliniczna niedoczynność tarczycy u dzieci. Adv Clin Exp Med 2004; 13: 171–176.
• Januszek-Trzącikowska A, Małecka-Tendera E. Subkliniczna niedoczynność tarczycy u otyłych dzieci. Post Hig Med Dośw (online) 2013; 67: 770–774.
• Iwańczak B, Krzesiek E, Barg E. Subkliniczna niedoczynność tarczycy u niemowląt i małych dzieci – analiza kliniczna. Adv Clin Exp Med 2004; 13: 279–283.
• Bednarek-Tupikowska G, Adamarczuk-Janczyszyn M., Rakowska-Chort A, i wsp. Utajona niedoczynność tarczycy. Pol Arch Med Wew 2006; 116: 974–979.
• Lazar L, Frumkin RB, Battat E, et al. Natural history of thyroid function tests over 5 years in a large pediatric cohort. J Clin Endocrinol Metab 2009; 94: 1678–1682.
• Wu T, Fowers JW ., Tudiver F, et al. Subclinical disorders and cognitive performance among adolescents in the United States.BMC Pediatr 2006; 6: 1–6.
• Ergur AT, Taner Y, Ata E, et al. Neurocognitive functions in children and adolescents with subclinical hypothyroidism. J Clin Res Pediatr Endocrinol 2012; 4: 21–24.
• Aijaz NJ , Flaherty EM, Preston T, et al. Neurocognitive function in children with compensated hypothyroidism: lack of short term effects on or off thyroxin. BMC Endocr Disord 2006; 6: 2–8.
• Di Mase R, Cerbone M, Improda N, et al. Bone health in children with long-term idiopathic subclinical hypothyroidism. Ital J Pediatr 2012; 38: 56–61.
• Cerbone M, Bravaccio C, Capalbo D, et al. Linear growth and intellectual outcome in children with long-term idiopathic subclinical hypothyroidism. Eur J Endocrinol 2011; 164: 591–597.
• Rapa A, Monzani A, Moia S, et al. Subclinical hypothyroidism in children and adolescents: a wide range of clinical, biochemical,and genetic factors involved. J Clin Endocrinol Metab 2009; 94: 2414–2420.
• Wasniewska M, Salerno M, Cassio A, et al. Prospective evaluation of the natural course of idiopathic subclinical hypothyroidism in childhood and adolescence. Eur J Endocrinol 2009; 160: 417–421.
• Reinehr T. Thyroid function in the nutritionally obese child and adolescent. Curr Opin Pediatr 2011; 23: 415–420.
• Reinehr T, Isa A, de Sousa G, et al. Thyroid hormones and their relation to weight status. Horm Res 2008; 70: 51–57.
• Ittermann T, Thamm M, Wallaschofski H, et al. Serum thyroid-stimulating hormone levels are associated with blood pressure in children and adolescents. J Clin Endocrinol Metab 2012; 97: 828–834.
• Brienza C, Grandone A, Di Salvo G, et al. Subclinical hypothyroidism and myocardial function in obese children. Nutr Metab Cardiovasc Dis 2013; 23: 898–902.
• Cetinkaya E, Aslan A, Vidinlisan S, et al. Height improvement by L-thyroxine treatment in subclinical hypothyroidism. Pediatr Int 2003; 45: 534–537.
• Mohn A, Di Michele S, Di Luzio R, et al. The effect of subclinical hypothyroidism on metabolic control in children and adolescents with type 1 diabetes mellitus. Diabet Med 2002; 19: 70–73.
• Rozporządzenie Ministra Zdrowia z dnia 20.10.2014 r. zmieniające rozporządzenie w sprawie świadczeń gwarantowanych z zakresu podstawowej opieki zdrowotnej (Dz.U. z 2014 r., poz. 1440).